BIORA THERAPEUT.NEW -001
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-fre… Read more
Market Cap & Net Worth: BIORA THERAPEUT.NEW -001 (4ZU0)
BIORA THERAPEUT.NEW -001 (F:4ZU0) has a market capitalization of $19.25 Million (€18.76 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #34381 globally and #3952 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BIORA THERAPEUT.NEW -001's stock price €5.10 by its total outstanding shares 3677750 (3.68 Million).
BIORA THERAPEUT.NEW -001 Market Cap History: 2020 to 2024
BIORA THERAPEUT.NEW -001's market capitalization history from 2020 to 2024. Data shows change from $3.64 Billion to $19.25 Million (-71.38% CAGR).
BIORA THERAPEUT.NEW -001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BIORA THERAPEUT.NEW -001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 4ZU0 by Market Capitalization
Companies near BIORA THERAPEUT.NEW -001 in the global market cap rankings as of March 18, 2026.
Key companies related to BIORA THERAPEUT.NEW -001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
BIORA THERAPEUT.NEW -001 Historical Marketcap From 2020 to 2024
Between 2020 and today, BIORA THERAPEUT.NEW -001's market cap moved from $3.64 Billion to $ 19.25 Million, with a yearly change of -71.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €19.25 Million | +3980.00% |
| 2023 | €471.89K | -7.13% |
| 2022 | €508.13K | -99.97% |
| 2021 | €1.64 Billion | -54.92% |
| 2020 | €3.64 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 27th, 2025 the market cap of BIORA THERAPEUT.NEW -001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.25 Million USD |
| MoneyControl | $19.25 Million USD |
| MarketWatch | $19.25 Million USD |
| marketcap.company | $19.25 Million USD |
| Reuters | $19.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.